Found 5 matching trials
ADVM-022 Intravitreal Gene Therapy for DME
PHASE2A Phase 2, Multi-Center, Randomized, Double-Masked\*, Active Controlled Stu...
Location
Adverum Clinical Site
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
PHASE3This is a multi-center, randomized, double-masked, active-comparator-contro...
Location
Adverum Clinical Site 245
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
PHASE2The purpose of this study is to evaluate safety, effectiveness and durabili...
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
N/AADVM-022-07 is an observational long-term extension (OPTIC-EXT) study asses...
Status
Active Not Recruiting
Location
Adverum Clinical Site
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
PHASE3This is a multi-center, randomized, double-masked, active-comparator-contro...
Status
Active Not Recruiting
Location
Adverum Clinical Site 223